Haemostasis, investigation and disorders Flashcards

1
Q

What are the principles of haemotasis?

A

Platelets- normal number, normal function
Functional coagulation cascade
Normal vascular endothelium

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

Describe the ultrastructure of a platelet

A
Membrane glycoproteins- 
Metabolites
Receptors for primary agonists
Dense granules- ADP/ATP, calcium ion, serotonin
Lysosomal granules
Mitochondria
a-granules- VWF fibrinogen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What are the three distinct stages involved in the formation of a platelet rich thrombus?

A

Platelet adhesion
Platelet activation/ secretin
Platelet aggregation

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

Describe the process

?

A

The conversion of fibrinogen to fibrin by thrombin, and polymerisation of fibrin stabilises the platelet thrombus, resulting in a platelet- fibrin (white) clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

Describe platelet adhesion and activation

A

Normal platelets in flowing blood
Platelets adhere to damaged endothelium and undergo activation
Aggregation of platelets into a thrombus

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

Describe haemostatic plug formation

A

Primary= aggregation of platelets- clotting
Secondary= coagulation- thrombin- fibrin
Haemostatic clot

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What is early haemostatic response to injury triggered by?

A

Exposure to subendothelial collagen and the release of tissue factor

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What are types of platelet defects?

A

-Reduced number of platelets= thrombocytopenia
-Abnormal platelet function= mostly commonly drugs such as aspirin, clopidogrel, renal failure= uraemia- platelet dysfunction
Give rise to prolonged bleeding time

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What is thrombocytopenia?

A

Reduced number of platelets
Caused by- bone marrow failure, peripheral consumption (like immune TP disseminated intravascular coagulation- DIC, drug-induced)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What are types of abnormal vessel walls?

A

Scurvy
Ehlers Danlos syndrome
Henoch Schonlein purpura
Hereditary Haemorrhagic Telangiectasia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is abnormal interaction between platelets and vessel wall?

A

Von Willebrand disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

What is scurvy?

A

Classical findings of peri-follicular haemorrhage

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What is Hereditary Haemorrhagic Telangiectasia?

A

Also known as Osler Weber Rendu syndrome
Telangiectasia in skin, hut, lungs
Can bleed causing anaemia, blood loss

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Name drugs that inhibit platelet function

A

Aspirin and COX inhibitors
Reversible COX inhibitors (NSAIDs)
Dipyridamole (inhibits phosphodiesterase)
Thienopyridines (inhibit ADP-mediated activation- clopidogrel)
Integrin GP2b/ 3a receptor antagonsist (abciximab, tirofiban, prevent Fgn binding)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

How does the waterfall theory fail to accurately reflect haemostasis?

A
  • Patients with fX2 deficiency do not bleed
  • Patients with fV2 deficiency bleed abnormally
  • Patients with fV3 and f1X deficiency have severe haemorrhagic diathesis despite a normal extrinsic coagulation pathway
  • Patients with fX1 deficiency have a variable and mild bleeding diathesis
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What are the enzyme complexes of the coagulation cascade?

A

Extrinsic Tenase= V2a+TF
Intrinsic Tenase= V3a+ 1Xa
Prothrombinase= 2+2a

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
17
Q

What steps lead to coagulation?

A

Initiation
Amplification
Propagation
Termination

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
18
Q

What are the natural inhibitors of the coagulation cascade in regulation?

A
  • Tissue factor pathway inhibitor= TF-V2a complex/ fXa inhibited by TFP1
  • Antithrombin= Thrombin and fXa activity inhibited
  • Protein C pathway= inhibits fVa and fV3a
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
19
Q

How is Prothrombin time (PT) measured?

A

Measured in seconds

Reflects the ‘extrinsic pathway’ and the ‘common pathway’

20
Q

How is Activated Partial Thromboplastin Time (APTT) measured?

A

Measure in seconds

Reflects the ‘intrinsic pathway’ and the ‘common pathway’

21
Q

How is fibrinogen measured?

A

Measured in grams/L

Reflects the functional activity of the fibrinogen protein

22
Q

How are defects inherited and what is the incidence?

A
  • X11- no bleeding- Autosomal- relatively common
  • X1- autosomal- rare
  • 1X: Haemophilia B- X-Linked recessive- 1:30,000 live male births
  • V111: Haemophilia A- X-Linked recessive- 1:5000-8000 live male births
  • Von Willebrand Disease- autosomal dominant- common
  • V11- autosomal recessive- very rare
  • X, V, 11, 1, X111- autosomal recessive, very rare
23
Q

Describe Haemophilia A

A

X-linked recessive disorder= expressed in males, carried in females

  • 1:5-8000 males (30% cases are sporadic mutation)
  • Deficiency of fV111/ dysfunction
  • Severity same within different generations
24
Q

What are the clinical severities of haemophilia A?

A

-Clinical severity correlates to fV111 level=
Severe- frequent hemarthroses- less than 1%
Moderate- bleeding after minor trauma- 2-10%
Mild- bleeding after surgical challenge- 11-30%
Normal= 50-150%

25
Q

What is the traditional management of haemophilia?

A
  • Supportive measures
  • Replacement of missing clotting protein
  • Antifibrinolytic agents
26
Q

What are supportive measures for haemophilia treatment?

A

Ice
Immobilisation
Rest

27
Q

What are missing clotting proteins replaced by in haemophilia treatment?

A

Coagulation factor concentrates (plasma-derived, recombinant, extended half-life products)
Desmopressin (DDAVP)- used to increase factor V111 levels in mild/ moderate haemophilia A
Novel therapies- monoclonal antibodies, knock-out AT

28
Q

What are antifibrinolytic agents in haemophilia treatment?

A

Tranexamic acid

29
Q

Clinical presentations of congenital haemophilia

A

Hemarthroses
Muscle bleeds
Soft tissue bleeds

30
Q

Clinical presentations of acquired haemophilia

A
Large haematomas 
Gross haematuria
Retropharyngeal and retroperitoneal haematomas
Cerebral haemorrhages
Compartment syndromes
31
Q

What types of treatment/ services are involved in haemophilia management?

A
Specialised centres- Comprehensive Care Haemophilia Centre
Multidisciplinary Approach
Home treatment
Patient Education and Social Support
Physiotherapy, Psychology
Orthopaedic advice and treatment
Treat and diagnosis of Liver Disease
Specialised management for HIV positive patients
Genetic counselling
32
Q

What are the roles of the Von Willebrand Factor?

A

Promote platelet adhesion to subendothelium at high shear rates
Carrier molecule for FV111

33
Q

Describe Von Willebrand disease

A

Most common heritable bleeding disorder= mainly autosomal dominant, both sexes
Associated with defective primary haemostasis
Variable reduction in Factor V111 levels= mucocutaneous bleeding including menorrhagia, post-operative and post partum bleeding

34
Q

Describe the autosomal dominant inheritance of Von Willebrand Disease

A

Variable penetrance for mild types

Diagnosis of mild vWD difficult due to confounding factors- blood group O: lowers VWF levels

35
Q

Describe the management of Von Willebrand Disease

A

Antifibrinolytics: tranexamic acid
DDAVP (for type 1 vWD)
Factor concentrates containing vWD= plasma derived; no recombinant concentrates yet available, vaccination against hepatitis A and B
Contraceptive pill for menorrhagia

36
Q

What are the types of causes of acquired coagulation disorders?

A

Underproduction of coagulation factors
Anticoagulants
Immune
Consumption of coagulation factors

37
Q

Describe underproduction of coagulation factors

A

Liver failure
Vitamin K deficiency- haemorrhagic disease of the new-born due to liver immaturity, lack of gut bacterial synthesis of vit k2 and fall in coagulation factors if breast fed- haemorrhage at days 2-4 or at 2 months
1mg vit K intramuscular at birth

38
Q

Name anticoagulants

A

Warfarin, direct oral anticoagulants

39
Q

Name immune acquired coagulation disorders

A

Acquired haemophilia

Acquired VW syndrome

40
Q

What leads to consumption of coagulation factors?

A

DIC- Disseminated intravascular coagulation

41
Q

How does liver disease lead to acquired coagulation disorder?

A

Reduced hepatic synthesis of clotting factors
Thrombocytopenia secondary to hypersplenism (enlarged spleen)
Reduced vitamin K absorption due to cholestatic jaundice causing deficiencies of factors 11, V11, 1X AND X
Treat with plasma products and platelets to cover procedures and vitamin K

42
Q

Describe the syndrome DIC

A
  • An acquired syndrome of systematic intravascular activation of coagulation- thrombin explosion
  • Widespread deposition of fibrin in circulation
  • Tissue ischaemia and multi-organ failure
  • Consumption of platelets and coagulation factors to generate thrombin, may induce severe bleeding
  • To maintain vascular patency, plasmin generated in excess, leads to fibrinogenolysis
43
Q

Describe the aetiology of DIC

A
  • Sepsis- G+ or -ve sepsis, fungal infection, parasitic infection
  • Tumour- solid, haematological (Acute Promyelocytic Leukaemia)
  • Trauma- fat embolism, head injury, burns, lightning strikes
  • Pancreatitis
  • Obstetric- amniotic fluid embolism, abruptio placentae, pre-eclampsia/ eclampsia syndrome
  • Vascular- Kasabach Merritt syndrome (haemangioma) (incidence of DIC is 25%), aortic aneurysm (incidence of DIC 0.5-0%)
  • Toxic- recreational drugs, snake bites, bugs, bats, caterpillars, creepy crawlies
  • Transfusion of ABO incompatible cells
44
Q

What might histology o DIC show?

A

Patient with metastatic breast cancer- peripheral blood smear, bone marrow aspirate
Red cell fragments- examination of the peripheral blood film may show red cell fragments

45
Q

Describe DIC coagulation parameters

A

Prolonged prothrombin time (PT)
Prolonged activated partial thromboplastin time (APTT)
Low fibrinogen
=markers of consumption of coagulation factors
Raised D-dimers= marker of increased fibrinolysis